Literature DB >> 20203156

B cells limit repair after ischemic acute kidney injury.

Hye Ryoun Jang1, Maria Teresa Gandolfo, Gang Jee Ko, Shailesh R Satpute, Lorraine Racusen, Hamid Rabb.   

Abstract

There is no established modality to repair kidney damage resulting from ischemia-reperfusion injury (IRI). Early responses to IRI involve lymphocytes, but the role of B cells in tissue repair after IRI is unknown. Here, we examined B cell trafficking into postischemic mouse kidneys and compared the repair response between control (wild-type) and muMT (B cell-deficient) mice with and without adoptive transfer of B cells. B cells infiltrated postischemic kidneys and subsequently activated and differentiated to plasma cells during the repair phase. Plasma cells expressing CD126 increased and B-1 B cells trafficked into postischemic kidneys with distinct kinetics. An increase in B lymphocyte chemoattractant in the kidney preceded B cell trafficking. Postischemic kidneys of muMT mice expressed higher IL-10 and vascular endothelial growth factor and exhibited more tubular proliferation and less tubular atrophy. Adoptive transfer of B cells into muMT mice reduced tubular proliferation and increased tubular atrophy. Treatment with anti-CD126 antibody increased tubular proliferation and reduced tubular atrophy in the late repair phase. These results demonstrate that B cells may limit the repair process after kidney IRI. Targeting B cells could have therapeutic potential to improve repair after IRI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203156      PMCID: PMC2844308          DOI: 10.1681/ASN.2009020182

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  50 in total

1.  In situ demonstration of renal tubular regeneration using the monoclonal antibody Ki67.

Authors:  P A Hall; R A Greenwood; A J d'Ardenne; D A Levison
Journal:  Nephron       Date:  1988       Impact factor: 2.847

2.  The effect of iloprost on renal dysfunction after renal I/R using cystatin C and beta2-microglobulin monitoring.

Authors:  M Orkun Sahsivar; Cüneyt Narin; Aysel Kiyici; Hatice Toy; Erdal Ege; Ali Sarigül
Journal:  Shock       Date:  2009-11       Impact factor: 3.454

3.  B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.

Authors:  R John Looney; Jennifer H Anolik; Debbie Campbell; Raymond E Felgar; Faith Young; Lois J Arend; James A Sloand; Joseph Rosenblatt; Iñaki Sanz
Journal:  Arthritis Rheum       Date:  2004-08

Review 4.  Endothelial injury and dysfunction: role in the extension phase of acute renal failure.

Authors:  Bruce A Molitoris; Timothy A Sutton
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

5.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

Authors:  Minnie Sarwal; Mei-Sze Chua; Neeraja Kambham; Szu-Chuan Hsieh; Thomas Satterwhite; Marilyn Masek; Oscar Salvatierra
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

6.  Which is more effective in the prevention of renal ischemia-reperfusion-induced oxidative injury in the early period in mice: interleukin (IL)-10 or anti-IL-12?

Authors:  Tülay Köken; Mustafa Serteser; Ahmet Kahraman; Gökhan Akbulut; Osman Nuri Dilek
Journal:  Clin Biochem       Date:  2004-01       Impact factor: 3.281

7.  Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion.

Authors:  Francine B C Lemos; Jan N M Ijzermans; Pieter E Zondervan; Annemiek M A Peeters; Sandra van den Engel; Wendy M Mol; Willem Weimar; Carla C Baan
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

8.  IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice.

Authors:  M Mihara; N Takagi; Y Takeda; Y Ohsugi
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

9.  Proliferative activity of intrinsic cell populations in the normal human kidney.

Authors:  T Nadasdy; Z Laszik; K E Blick; L D Johnson; F G Silva
Journal:  J Am Soc Nephrol       Date:  1994-06       Impact factor: 10.121

10.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

Authors:  M R Weiser; J P Williams; F D Moore; L Kobzik; M Ma; H B Hechtman; M C Carroll
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  45 in total

1.  Loss of regulatory T cell function on anti-inflammation is correlated with increased risk of acute kidney injury development in patients with primary glomerulonephritis.

Authors:  Qin Dong; Chen Cai; Feng Gao; Ziqian Xu; Yuan Fang; Lijie Wang; Jie Cui
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

3.  Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney.

Authors:  Maria N Martina; Sanjeev Noel; Ankit Saxena; Samatha Bandapalle; Richa Majithia; Chunfa Jie; Lois J Arend; Mohamad E Allaf; Hamid Rabb; Abdel Rahim A Hamad
Journal:  J Am Soc Nephrol       Date:  2015-08-27       Impact factor: 10.121

Review 4.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 5.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

6.  Quantitative Three-Dimensional Tissue Cytometry to Study Kidney Tissue and Resident Immune Cells.

Authors:  Seth Winfree; Shehnaz Khan; Radmila Micanovic; Michael T Eadon; Katherine J Kelly; Timothy A Sutton; Carrie L Phillips; Kenneth W Dunn; Tarek M El-Achkar
Journal:  J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 10.121

7.  Hif1α Deletion Limits Tissue Regeneration via Aberrant B Cell Accumulation in Experimental Pancreatitis.

Authors:  Kyoung Eun Lee; Michelle Spata; Richard Maduka; Robert H Vonderheide; M Celeste Simon
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

Review 8.  B cells in transplant tolerance and rejection: friends or foes?

Authors:  Robin Schmitz; Zachary W Fitch; Paul M Schroder; Ashley Y Choi; Annette M Jackson; Stuart J Knechtle; Jean Kwun
Journal:  Transpl Int       Date:  2020-01       Impact factor: 3.782

Review 9.  Immune system modulation of kidney regeneration--mechanisms and implications.

Authors:  Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2014-04-29       Impact factor: 28.314

Review 10.  Acute kidney injury and chronic kidney disease: From the laboratory to the clinic.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nephrol Ther       Date:  2016-03-10       Impact factor: 0.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.